Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Nakagawa, Kiyohide"'
Autor:
SAWADA, Hiroyoshi, HUTAKATA, Yoshiko, KASAGAWA, Machiko, KAWAGUCHI, Masuko, HAMAKAWA, Jyunichi, KURATA, Masahiko, NAKAGAWA, Kiyohide, YONEDA, Michimasa, ASHIKAGA, Yoshio, HASEGAWA, Hideshi
Publikováno v:
京都産業大学現代体育研究所所報. 5:15-22
3
KJ00000609963
P
KJ00000609963
P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::9f547eb16ac4662762fbd04b06287aa0
https://ksu.repo.nii.ac.jp/records/8861
https://ksu.repo.nii.ac.jp/records/8861
Autor:
SAWADA, Hiroyoshi, HUTAKATA, Yoshiko, KASAGAWA, Machiko, KAWAGUCHI, Masuko, HAMAKAWA, Jyunichi, KURATA, Masahiko, NAKAGAWA, Kiyohide, YONEDA, Michimasa, MURAKAMI, Hiromi, TANAKA, Nobuo
Publikováno v:
京都産業大学現代体育研究所所報. 5:23-34
4
KJ00000609964
P
KJ00000609964
P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::64c21de4dd47330ea7a5487bffb57ad0
https://ksu.repo.nii.ac.jp/records/8862
https://ksu.repo.nii.ac.jp/records/8862
Autor:
Furusawa, Taroh, Mishina, Teruo, Furudama, Hiroshi, Itoh, Mikio, Inoue, Susumu, Fukuyama, Takuo, Higashi, Shin, Yamamoto, Masakazu, Hiratake, Yasusuke, Ooe, Hiroshi, Maegawa, Mikio, Hida, Shuichi, Nakagawa, Kiyohide, Muguruma, Yuji, Nakahashi, Hisamitsu, Aoki, Tadashi, Tanaka, Toshiyuki, Soma, Takaomi, Itoh, Hitoshi, Ono, Toshihiko
Publikováno v:
泌尿器科紀要. 40(9):853-860
1) 1群82例(CPDX-PR 200mg/day, 分二, 3日間投与)のUTI薬効評価基準による総合臨床効果は, 著効64例, 有効17例, 無効1例で有効率98.8%であった。2) 2群の35例(CPDX-PR 200mg/day, 分二, 4～7日間投与投与)の
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::d85116ed2d76c7f5c563fc34cc77f39d
http://hdl.handle.net/2433/115342
http://hdl.handle.net/2433/115342
Autor:
Sonoda, Takao, Rokujyo, Masatoshi, Kanemoto, Toshitaka, Goto, Shiro, Ohori, Tsutomu, Kubo, Takashi, Ohinada, Mitsuru, Seo, Kikuo, Nakano, Nobumichi, Yoshizaki, Hiroshi, Chiba, Ryuichi, Endo, Hiroshi, Takeda, Hirohisa, Hiraga, Seigo, Miyazaki, Kazuoki, Ishido, Tetsuo, Kawada, Yukimichi, Tei, Kanhim, Yamaguchi, Ryuji, Nishikawa, Yoshio, Tsubomoto, Satoru, Nakaarai, Kunio, Ozawa, Mitsuru, Ezaki, Yojiro, Nakagawa, Kiyohide, Konya, Hiroaki, Hirayama, Masaaki, Sato, Hideo, Kondo, Atsushi, Tokunaga, Hiroshi, Sakaguchi, Hiroshi, Iwasaki, Shotaro, Miura, Seiran, Kawamura, Shingo, Naito, Chikayuki, Aso, Yoshiro
Publikováno v:
泌尿器科紀要. 24(2):109-128
Therapeutic effect of Robaveron was evaluated by means of the double blind method with Distigmine Bromide as a standard drug and a placebo. The drugs were administered in a double dummy fashion. The Robaveron group showed the best result compared wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::868cc63a5daa782deca7a63523960149
http://hdl.handle.net/2433/122175
http://hdl.handle.net/2433/122175
Autor:
SONODA, Takao, KOIDE, Takuo, OKA, Toshitsugu, SAKAGUCHI, Hiroshi, ITATANI, Hiroaki, OHKAWA, Tadashi, EBISUNO, Shoichi, MORIMOTO, Shigeyoshi, YOSHIDA, Osamu, OKADA, Yusaku, NAKAGAWA, Kiyohide, FUKUYAMA, Takuo, OGURA, Keiji, HAYASHI, Tadashi, ARAI, Yoichi, KURITA, Takashi, YACHIKU, Sunao, KOHRI, Kenjiro, TADA, Shigeru, YANAGAWA, Makoto, SAITO, Kaoru, MORI, Toru, SUZUKI, Norimoto, HIRAISHI, Koji, NAKAMURA, Shoichiro, TAKEUCHI, Masafumi, WAKATSUKI, Akira, TAKEUCHI, Hideo
Publikováno v:
泌尿器科紀要. 31(11):2071-2079
1) 150例の再発性・特発性蓚酸カルシウム尿路結石症を対象として, 最低2年間を目標として, アロプリノール投与による結石再発予防の臨床的検討をおこなった.2)検討可能症例134例(男性113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::6b1e343b7a4ce492db7c5c5390e61b7a
http://hdl.handle.net/2433/118649
http://hdl.handle.net/2433/118649
Autor:
Yoshida, Osamu, Kiriyama, Tadao, Okada, Kenichiro, Takahashi, Yoichi, Hida, Shuichi, Matsuda, Koji, Horii, Yasuki, Nakagawa, Kiyohide, Fukuyama, Takuo, Nakagawa, Takashi, Sasaki, Miharu, Nishimura, Kazuo, Machida, Shuzo, Tanaka, Yoichi
Publikováno v:
泌尿器科紀要. 29(5):527-534
泌尿器科的疾患患者278例に, Cephalothin (CET)およびCephapirin (CEPR)を経静脈的に投与したときの, 静脈炎の発生について比較検討した.CETまたはCEPR 2 gを1日2回, 5～7日間点滴静注にて投与した.CET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::09c7ac2ccb424e01c07d1b77db159268
http://hdl.handle.net/2433/120169
http://hdl.handle.net/2433/120169
Autor:
Yoshida, Osamu, Okada, Kenichiro, Okabe, Tatsushiro, Okada, Yusaku, Watanabe, Hiroki, Mishina, Teruo, Miyakoda, Keiichi, Tomoyoshi, Tadao, Takeuchi, Hideo, Ikeda, Tatsuo, Hayashi, Tadashi, Akita, Yasutoshi, Fujisawa, Akio, Ueyama, Hidemaro, Ito, Mikio, Ito, Hitoshi, Okamura, Yasuhiko, Hiratake, Yasusuke, Yamamoto, Noriyuki, Ono, Toshihiko, Kondo, Morihiro, Iwamoto, Noriyuki, Fukuda, Toyohumi, Nakamura, Toyoki, Kaiho, Hiroo, Nakagawa, Kiyohide, Fukuyama, Takuo, Kohnami, Teruo, Kaneda, Yasuo, Nakahashi, Hisamitsu, Aoki, Tadashi, Tabata, Yoshihisa
Publikováno v:
泌尿器科紀要. 26(8):1051-1057
Flavoxate was administered to 225 patients with pollakisuria and bladder irritation, who visited 12 urological clinics in Keiji district. Improvement of urinary frequency was observed in patients with nervous pollakisuria, cystitis, chronic prostatit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::4ff983bbb45859256729f1f22ae32d9c
http://hdl.handle.net/2433/122700
http://hdl.handle.net/2433/122700
Autor:
YAMAUCHI, Tamio, KAWAMURA, Juichi, YOSHIDA, Osamu, FUKUYAMA, Takuo, OGURA, Keishi, NAKAGAWA, Kiyohide
Publikováno v:
泌尿器科紀要. 31(9):1539-1552
腎癌に対してα-Interferon (γ-IFN-αA)の抗腫瘍効果を組織学的に検討した.1)対象症例は14例で, 腎摘除後の転移症例10例, 原発巣に対する塞栓術だけをおこなった症例2例, 手術をおこなわないも
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::28b30592510431b5fab970a776da704b
http://hdl.handle.net/2433/118611
http://hdl.handle.net/2433/118611
Autor:
Yoshida, Osamu, Okada, Ken-ichiro, Hiei, Tetsuhiko, Ito, Hitoshi, Ito, Mikio, Komatsu, Yosuke, Nakagawa, Kiyohide, Fukuyama, Takuo, Yamashita, Akiyo, Kuze, Masuji, Miyagawa, Mieko, Tsuchiya, Masataka
Publikováno v:
泌尿器科紀要. 25(5):499-507
Twenty-eight patients with benign prostatic hypertrophy ranging in age from 61 to 84 were treated with TSAA-291 for 12 weeks. 1. Seventeen patients received TSAA-291 in a dose of 200 mg once a week. The clinical response was favorable in 10 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::6eb9f2d48320f402de09e3df5b3c0ea5
http://hdl.handle.net/2433/122420
http://hdl.handle.net/2433/122420
Autor:
Yoshida, Osamu, Okada, Kenichiro, Okada, Yusaku, Oishi, Kenji, Nakagawa, Kiyohide, Fukuyama, Takuo, Ueyama, Hidemaro, Ito, Mikio, Ito, Hitoshi
Publikováno v:
泌尿器科紀要. 28(10):1301-1313
The effect of gestonorone caproate (GC) on the pituitary-gonadal axis was studied in 14 patients with benign prostatic hypertrophy (BPH). The drug was injected once a week for 12 weeks at the dosage of 200 mg, and after that once every 2 weeks for 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::ed2fb4427f45fbc909f2caa84f90b839
http://hdl.handle.net/2433/123254
http://hdl.handle.net/2433/123254